Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
Cisplatin (CDDP) remains a key drug for patients with advanced bladder cancer (BC), despite the emergence of new therapeutic agents; thus, the identification of factors contributing to CDDP treatment resistance is crucial. As acidity of the tumor microenvironment has been reported to be associated w...
Saved in:
Main Authors: | Kaede Hiruma, Vladimir Bilim, Akira Kazama, Yuko Shirono, Masaki Murata, Yoshihiko Tomita |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/47/1/43 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
by: Wenhui Wang, et al.
Published: (2025-01-01) -
Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
by: Atenea A. Perez-Serna, et al.
Published: (2025-01-01) -
Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis
by: Alia Khalil, et al.
Published: (2025-01-01) -
Potential therapeutic effect of thymoquinone on cisplatin-induced hepatotoxicity in rats
by: Sercan Kaya, et al.
Published: (2024-03-01) -
COMBINED TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER
by: I. V. Chernyshev, et al.
Published: (2016-01-01)